Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$0.4 - $0.67 $295 - $494
738 New
738 $0
Q2 2022

Aug 11, 2022

SELL
$2.52 - $14.42 $59,194 - $338,725
-23,490 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$12.69 - $20.72 $4,200 - $6,858
331 Added 1.43%
23,490 $327,000
Q4 2021

Feb 10, 2022

SELL
$19.7 - $23.71 $9,712 - $11,689
-493 Reduced 2.08%
23,159 $480,000
Q3 2021

Nov 12, 2021

BUY
$21.32 - $29.36 $21,320 - $29,360
1,000 Added 4.41%
23,652 $527,000
Q2 2021

Aug 05, 2021

BUY
$17.01 - $24.14 $1,394 - $1,979
82 Added 0.36%
22,652 $535,000
Q1 2021

May 06, 2021

SELL
$21.8 - $36.52 $42,379 - $70,994
-1,944 Reduced 7.93%
22,570 $542,000
Q4 2020

Feb 10, 2021

BUY
$23.44 - $31.85 $24,260 - $32,964
1,035 Added 4.41%
24,514 $658,000
Q3 2020

Nov 12, 2020

SELL
$25.1 - $53.8 $79,014 - $169,362
-3,148 Reduced 11.82%
23,479 $681,000
Q2 2020

Aug 13, 2020

BUY
$16.0 - $40.99 $209,712 - $537,255
13,107 Added 96.95%
26,627 $1.09 Million
Q1 2020

May 06, 2020

BUY
$7.79 - $19.91 $8,397 - $21,462
1,078 Added 8.66%
13,520 $255,000
Q4 2019

Feb 05, 2020

BUY
$8.01 - $12.48 $4,405 - $6,864
550 Added 4.62%
12,442 $151,000
Q3 2019

Oct 23, 2019

BUY
$8.7 - $23.46 $103,460 - $278,986
11,892 New
11,892 $113,000

Others Institutions Holding VAPO

About VAPOTHERM INC


  • Ticker VAPO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,697,200
  • Market Cap $57.9M
  • Description
  • Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...
More about VAPO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.